Kornitzer Capital Management Inc. KS Lowers Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)

Kornitzer Capital Management Inc. KS lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 9.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,647 shares of the medical research company’s stock after selling […]

Related Keywords

United States ,Canada ,Blackrock ,Nova Scotia ,America ,Michael Crowley ,Citigroup ,Bio Rad Laboratories Company Profile ,America Corp ,Securities Exchange Commission ,Bio Rad Laboratories Inc ,Kornitzer Capital Management Inc ,Royal Bank ,Brown Advisory Inc ,Exchange Commission ,Blackrock Inc ,Vanguard Group Inc ,Kornitzer Capital Management ,Bio Rad Laboratories ,Free Report ,Capital Management ,Street Corp ,Rad Laboratories Trading Down ,Rad Laboratories ,Get Free Report ,Life Science ,Visit Holdingschannel ,Bio Rad Laboratories Daily ,Nyse Bio ,Bio ,Medical ,09057220 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,